Alaunos Acquires Velaris in Stock Merger, Secures $350 Million PIPE
Alaunos Therapeutics completed a stock-for-stock acquisition of Velaris and signed a $350 million PIPE to fund development of Velaris programs.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.